 SAN DIEGO, Oct. 25, 2022 GLOBE NEWSWIRE -- aTyr Pharma, Inc. Nasdaq: LIFE, a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer, will present a corporate overview at the Jefferies London Healthcare Conference, which is scheduled to take place November 15 17, 2022, in London, U.K. 